Skip to main content

Peer Review reports

From: NSMCE2, a novel super-enhancer-regulated gene, is linked to poor prognosis and therapy resistance in breast cancer

Original Submission
29 Apr 2022 Submitted Original manuscript
23 May 2022 Reviewed Reviewer Report
9 Jun 2022 Reviewed Reviewer Report
20 Jul 2022 Author responded Author comments - Paola Betancur
Resubmission - Version 2
20 Jul 2022 Submitted Manuscript version 2
12 Aug 2022 Reviewed Reviewer Report
14 Aug 2022 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
7 Sep 2022 Editorially accepted
12 Oct 2022 Article published 10.1186/s12885-022-10157-7

You can find further information about peer review here.

Back to article page